Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1984 Jan;49(1):5–10. doi: 10.1038/bjc.1984.2

Specificity of tumour associated transplantation antigens (TATA) of different clones from the same tumour.

M F Woodruff, J D Ansell, B A Hodson, H S Micklem
PMCID: PMC1976682  PMID: 6197985

Abstract

The TATA of two clones from the same murine methylcholanthrene-induced fibrosarcoma have been investigated by immunizing syngeneic mice with irradiated cells of one or both clones and challenging them 14 days later with viable cells. The tumour had been induced in a female backcross CBA mouse heterozygous for the A and B alloenzymes of phosphoglycerate kinase-1 (PGK-1). One clone expressed A and the other B, and both A and B hosts were used in the experiments. Each clone was found to possess strong TATA but there was no demonstrable cross reactivity. The clonal composition of tumours produced by inoculating mice with a mixture of the two clones was profoundly altered by prior immunization with one of them. A second experiment was performed with 3 clones from another tumour; these expressed PGK-1 A, B and AB respectively. Again, there was no evidence of immunological cross reactivity between the A and B clones, but there was some cross reactivity between the A clone and AB clone. These results, coupled with previous observations of changes in the clonal composition of pleoclonal murine fibrosarcomas in culture and on transplantation, suggest that the antigenic specificity of these tumours is less stable than is commonly supposed.

Full text

PDF
5

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BALDWIN R. W. Immunity to methylcholanthrene-induced tumours in inbred rats following atrophy and regression of the implanted tumours. Br J Cancer. 1955 Dec;9(4):652–657. doi: 10.1038/bjc.1955.70. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Brecher G., Ansell J. D., Micklem H. S., Tjio J. H., Cronkite E. P. Special proliferative sites are not needed for seeding and proliferation of transfused bone marrow cells in normal syngeneic mice. Proc Natl Acad Sci U S A. 1982 Aug;79(16):5085–5087. doi: 10.1073/pnas.79.16.5085. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bücher T., Bender W., Fundele R., Hofner H., Linke I. Quantitative evaluation of electrophoretic allo-and isozyme patterns. FEBS Lett. 1980 Jun 30;115(2):319–324. doi: 10.1016/0014-5793(80)81197-5. [DOI] [PubMed] [Google Scholar]
  4. DuBois G. C., Law L. W., Appella E. Purification and biochemical properties of tumor-associated transplantation antigens from methylcholanthrene-induced murine sarcomas. Proc Natl Acad Sci U S A. 1982 Dec;79(24):7669–7673. doi: 10.1073/pnas.79.24.7669. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. GLOBERSON A., FELDMAN M. ANTIGENIC SPECIFICITY OF BENZO(A)PYRENE-INDUCED SARCOMAS. J Natl Cancer Inst. 1964 Jun;32:1229–1243. doi: 10.1093/jnci/32.6.1229. [DOI] [PubMed] [Google Scholar]
  6. Klein G., Oettgen H. F. Immunologic factors involved in the growth of primary tumors in human or animal hosts. Cancer Res. 1969 Sep;29(9):1741–1746. [PubMed] [Google Scholar]
  7. Lennox E. S., Lowe A. D., Cohn J., Evan G. Specific antigens on methylcholanthrene-induced tumors of mice. Transplant Proc. 1981 Dec;13(4):1759–1761. [PubMed] [Google Scholar]
  8. PREHN R. T., MAIN J. M. Immunity to methylcholanthrene-induced sarcomas. J Natl Cancer Inst. 1957 Jun;18(6):769–778. [PubMed] [Google Scholar]
  9. Parmiani G., Pierotti M. A. Generation of TSTA diversity. Looking for testable hypotheses. Cancer Immunol Immunother. 1983;14(3):133–136. doi: 10.1007/BF00205350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Pimm M. V., Embleton M. J., Baldwin R. W. Multiple antigenic specificities within primary 3-methylcholanthrene-induced rat sarcomas and metastases. Int J Cancer. 1980 May 15;25(5):621–629. doi: 10.1002/ijc.2910250512. [DOI] [PubMed] [Google Scholar]
  11. Prehn R. T. Analysis of antigenic heterogeneity within individual 3-methylcholanthrene-induced mouse sarcomas. J Natl Cancer Inst. 1970 Nov;45(5):1039–1045. [PubMed] [Google Scholar]
  12. Prehn R. T. Do tumors grow because of the immune response of the host? Transplant Rev. 1976;28:34–42. doi: 10.1111/j.1600-065x.1976.tb00191.x. [DOI] [PubMed] [Google Scholar]
  13. Reddy A. L., Fialkow P. J. Multicellular origin of fibrosarcomas in mice induced by the chemical carcinogen 3-methylcholanthrene. J Exp Med. 1979 Oct 1;150(4):878–887. doi: 10.1084/jem.150.4.878. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Simrell C. R., Klein P. A. Antibody responses of tumor-bearing mice to their own tumors captured and perpetuated as hybridomas. J Immunol. 1979 Nov;123(5):2386–2394. [PubMed] [Google Scholar]
  15. Woodruff M. F., Ansell J. D., Forbes G. M., Gordon J. C., Burton D. I., Micklem H. S. Clonal interaction in tumours. Nature. 1982 Oct 28;299(5886):822–824. doi: 10.1038/299822a0. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES